CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 6, 2024 · earnings

ORMP earnings: a negative outcome, -12.0%

On March 6, 2024, ORAMED PHARMACEUTICALS INC. reached its earnings. The result was a negative outcome, and the stock moved -12.0% in the window around the event. It had already run +30.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$3.26
1d before
$2.87
Event day
$2.86
1d after
$2.94
5d after

Pre-catalyst setup

+30.5%
30-day run-up
6863%
30-day volatility
0.5×
volume spike